Form D · Pharmaceuticals
Seneca Therapeutics, Inc.
Blue Bell, PA · CIK 0001778151
Offering snapshot reported Feb 7, 2025 · SEC filing
- Reported sold
- $1.64M Offering amount: $8M
- Investors reported
- 68 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 7, 2025 | Initial | $1,636,582 | No comparison | 68 | SEC filing |
| Dec 23, 2022 | Amendment | $7,711,958 | $2,715,323vs Dec 22, 2021 | 114 | SEC filing |
| Dec 22, 2021 | Amendment | $4,996,635 | $4,269,766vs Apr 2, 2021 | 79 | SEC filing |
| Apr 2, 2021 | Initial | $726,869 | No comparison | 34 | SEC filing |
| Jun 23, 2020 | Initial | $500,999 | No comparison | 15 | SEC filing |
| Mar 19, 2020 | Amendment | $820,000 | $755,000vs Nov 22, 2019 | 14 | SEC filing |
| Nov 22, 2019 | Initial | $65,000 | No comparison | 2 | SEC filing |
| Aug 8, 2019 | Amendment | $380,000 | $325,000vs May 30, 2019 | 7 | SEC filing |
| May 30, 2019 | Initial | $55,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $65.5K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-537724
Plus certain warrants to purchase shares of the Company's stock.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Walter Greenblatt & Associates, LLC | 129291 |
Source: Form D, filed Feb 7, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cuong Do | Director, Executive |
| Paul Hallenbeck | Director, Executive |
| James Hussey | Director, Executive |
| Mark Kerschner | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
202 St. Andrews Court
Blue Bell, PA, 19422
Blue Bell, PA, 19422